Table III.
Count and acuity by chief complaint of pediatric ED use during the first 30 days of the COVID-19 stay-at-home order
| Chief complaints | Baseline |
2020 |
P value∗ |
||
|---|---|---|---|---|---|
| Visits per year (n ± SD) | High acuity (%)† | Visits (n) | High acuity (%)† | ||
| Trauma | 1274 ± 102 | 34.7 | 449 | 44.3 | <.001 |
| Respiratory | 1538 ± 139 | 64.9 | 433 | 59.8 | .36 |
| Fever | 1229 ± 233 | 30.2 | 394 | 51.8 | <.001 |
| Abdominal pain | 1100 ± 192 | 54.4 | 336 | 69.7 | <.001 |
| Rash | 368 ± 50 | 14.2 | 85 | 28.2 | .003 |
| Seizure | 131 ± 19 | 90.0 | 83 | 97.6 | .282 |
| Sore throat | 176 ± 32 | 15.9 | 72 | 15.3 | 0.526 |
| Psychiatric emergency | 204 ± 33 | 99.4 | 58 | 96.6 | .088 |
| Foreign body | 88 ± 3 | 38.9 | 55 | 30.9 | .288 |
| Chest pain | 119 ± 6 | 46.3 | 50 | 40.0 | .45 |
| Eye emergency | 231 ± 40 | 25.7 | 48 | 47.9 | .002 |
| Dental problem | 53 ± 9 | 50.9 | 45 | 51.1 | 0.559 |
| Male GU | 58 ± 13 | 80.6 | 41 | 78.0 | .671 |
| Headache | 174 ± 35 | 72.0 | 38 | 73.7 | 0.494 |
| Abscess | 61 ± 3 | 85.3 | 38 | 100.0 | .006 |
| Ear pain | 230 ± 5 | 7.4 | 36 | 8.3 | .745 |
| Edema/swelling | 78 ± 3 | 69.8 | 33 | 84.9 | .098 |
| Sickle cell disease | 87 ± 7 | 100.0 | 32 | 100.0 | NA |
| Urination problem | 76 ± 6 | 48.9 | 31 | 61.3 | .251 |
| Ingestion | 25 ± 5 | 76 | 31 | 87.1 | .293 |
| Allergic reaction | 60 ± 4 | 69.3 | 29 | 86.2 | .075 |
| Other or missing | 1490 ± 57 | 61.4 | 531 | 69.1 | .001 |
GU, genitourinary.
∗
Bolded values statistically significant per Bonferroni family-wise error correction (P < .0016).
†
Percent of visits categorized as high acuity (ESI triage 1, 2, or 3).